Tactic Pharma LLC

13F Holdings History for Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Symbol: MNPR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 506K shares
Security Ownership: 7.5%

Robinson Chandler ownership in Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR)

2025-09-24 - Robinson Chandler has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 506K shares of Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR). This represents 7.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Robinson Chandler	7.5%		$18.3M	506K			$36.06	13D/A	9/24/2025	24 Sep 2025 20:59:11